Kilitch Drugs (India) reports standalone net loss of Rs 0.68 crore in the March 2017 quarter

Sales rise 21.11% to Rs 8.09 crore

Net loss of Kilitch Drugs (India) reported to Rs 0.68 crore in the quarter ended March 2017 as against net profit of Rs 0.58 crore during the previous quarter ended March 2016. Sales rose 21.11% to Rs 8.09 crore in the quarter ended March 2017 as against Rs 6.68 crore during the previous quarter ended March 2016.

For the full year,net loss reported to Rs 2.00 crore in the year ended March 2017 as against net loss of Rs 2.05 crore during the previous year ended March 2016. Sales rose 30.45% to Rs 27.16 crore in the year ended March 2017 as against Rs 20.82 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales8.096.68 21 27.1620.82 30 OPM %-10.14-9.13 --8.76-17.39 - PBDT-0.420.94 PL -1.24-0.88 -41 PBT-0.760.53 PL -2.56-2.49 -3 NP-0.680.58 PL -2.00-2.05 2

Powered by Capital Market - Live News